MNP LLP | Jotup

National Veterinary Association Calls on Federal Government to Address Severe Workforce Shortage

Retrieved on:

Wednesday, March 20, 2024

Establishment of a National Testing Centre for Internationally Educated Veterinarians Needed

Key Points:

The veterinary profession in Canada faces pressing challenges that demand immediate attention from the federal government.
"Given the severe workforce shortage in our profession, Canada needs a veterinary workforce enhancement program that supports expansion and innovation of clinical teaching, training, and research to develop the next generation of veterinarians in response to societal demands."
The workforce shortage poses a significant threat to the veterinary profession and its ability to provide quality care for its patients and clients.
The Canadian Veterinary Medical Association is the national and international voice for Canada's veterinarians, providing leadership and advocacy for veterinary medicine.

Amcomri Granted Management Cease Trader Order

Retrieved on:

Thursday, April 4, 2024

Annual, MNP, News, Bank statement, OTC, Fortnight, MNP LLP, National Policy

VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- Amcomri Entertainment Inc. (the “Company”) (Cboe CA: AMEN) (Frankfurt: 25YO) (OTC: AMNNF) announces that its principal regulator, the British Columbia Securities Commission, has accepted the Company's application for, and has granted, a management cease trade order (the “MCTO”) dated April 3, 2024.

Key Points:

VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- Amcomri Entertainment Inc. (the “Company”) (Cboe CA: AMEN) (Frankfurt: 25YO) (OTC: AMNNF) announces that its principal regulator, the British Columbia Securities Commission, has accepted the Company's application for, and has granted, a management cease trade order (the “MCTO”) dated April 3, 2024.
The Company’s board of directors and its management are working expeditiously to meet the Company’s obligations relating to the filing of the Annual Filings.
At this time, the Company anticipates being able to complete the Annual Filings on or about April 15, 2024.
The Company also confirms that there are no other material developments concerning the affairs of the Company that has not been generally disclosed.

Interfield Global Software Inc. Announces Delay in Filing of Annual Filings and Director Resignation

Retrieved on:

Monday, April 1, 2024

MNP, Policy, News, National instrument, Bank statement, File, MNP LLP, National Policy, Cryptocurrency

As a result, the Company will also be delayed in filing of its Annual Information Form for the year ended December 31, 2023 (the “AIF”).

Key Points:

As a result, the Company will also be delayed in filing of its Annual Information Form for the year ended December 31, 2023 (the “AIF”).
The Company has made all efforts and allocated all available resources to the preparation, completion and filing of the Annual Filings.
The Company’s auditors have also made significant efforts to complete their audit of the annual financial statements.
Upon filing its Annual Filings, the Company will also file its AIF.

Titan Medical Reports Fiscal Year 2023 Results

Retrieved on:

Friday, March 29, 2024

Titan, Indian stock exchange, Research, MNP, Development, TSX Venture Exchange, G&A, Medtronic, MD, MBA, TMD, TSX, Intuition, Transaction, MNP LLP

TORONTO, Ontario, March 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the fiscal year ended December 31, 2023.

Key Points:

TORONTO, Ontario, March 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the fiscal year ended December 31, 2023.
On August 21, 2023, the Company announced a licensing agreement with Auris Health, Inc., a Johnson & Johnson MedTech Company.
On October 18, 2023, the Company announced it had changed its auditor from BDO Canada LLP to MNP LLP.
As of December 31, 2023, Titan had cash of $7.5 million, compared to $3.3 million on December 31, 2022.

NEO Battery Materials Announces Change of Auditor to MNP LLP

Retrieved on:

Wednesday, March 20, 2024

NEO, MNP, Successor, National instrument, OTC, Former, Change, MNP LLP, Silicon, Audit

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that it has changed its auditors from DeVisser Gray LLP (“Former Auditor”) to MNP LLP (“Successor Auditor”), effective March 19, 2024.

Key Points:

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that it has changed its auditors from DeVisser Gray LLP (“Former Auditor”) to MNP LLP (“Successor Auditor”), effective March 19, 2024.
NEO Battery’s board of directors accepted the resignation of DeVisser Gray LLP and appointed MNP LLP as the new auditor of the Company, effective March 19, 2024, until the Company’s next annual general meeting of shareholders.
There were no reservations in the Former Auditor’s audit reports for any financial period during which the Former Auditor was the Company’s auditor.
There are no “reportable events” (as the term is defined in National Instrument 51-102 – Continuous Disclosure Obligations) between the Company and the Former Auditor.

Western Resources Reports AGM Results

Retrieved on:

Friday, March 15, 2024

Remuneration, Corporation, MNP, Cave, AGM, News, Executive Committee, Compensated emancipation, MNP LLP, Audit committee

Shuai Wei and Xiao Xing were appointed as Board Observers, and Jack Xue as Corporate Secretary.

Key Points:

Shuai Wei and Xiao Xing were appointed as Board Observers, and Jack Xue as Corporate Secretary.
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.
There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.
For more information on the contents of this release please contact Jack Xue, Corporate Secretary, at 306-924-9378.

STLLR Gold Appoints Successor Auditor

Retrieved on:

Monday, March 25, 2024

Natural Resources, Other Natural Resources, Mining, Minerals, Auditor, MNP, National instrument, TSX, Former, Chartered Professional Accountant, MNP LLP, Audit committee, Audit

STLLR Gold Inc. (TSX: STLR) (OTCQX: STLRF) (FSE: O9D) (“STLLR” or the “Company”) announces that it has changed its auditor from BDO Canada LLP, Chartered Professional Accountants (the “Former Auditor”) to MNP LLP (the “Successor Auditor”).

Key Points:

STLLR Gold Inc. (TSX: STLR) (OTCQX: STLRF) (FSE: O9D) (“STLLR” or the “Company”) announces that it has changed its auditor from BDO Canada LLP, Chartered Professional Accountants (the “Former Auditor”) to MNP LLP (the “Successor Auditor”).
At the request of the Company, the Former Auditor resigned as the auditor of the Company effective March 19, 2024, and the Board of Directors of the Company appointed the Successor Auditor as the Company’s auditor effective March 19, 2024, until the next Annual General Meeting of the Company.
The resignation of the Former Auditor as auditor of the Company has been approved by the Company's Audit Committee and its Board of Directors.
In accordance with NI 51-102, the notice of change of auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the Board of Directors of the Company and filed on SEDAR+ www.sedarplus.ca

Visionary Selects YCM CPA INC as its Independent Registered Public Accounting Firm

Retrieved on:

Wednesday, March 6, 2024

Artificial intelligence, CPA, MNP LLP, YCM, MNP, GV

TORONTO, March 6, 2024 /PRNewswire/ -- Visionary Holdings Inc. (NASDAQ: GV) ("Visionary" or the "Company"), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced that, effective March 4, 2024, the Company has appointed YCM CPA Inc. (the "Successor Auditors") as successor auditor of the Company and for the fiscal year ending March 31, 2024 to replace MNP LLP.

Key Points:

TORONTO, March 6, 2024 /PRNewswire/ -- Visionary Holdings Inc. (NASDAQ: GV) ("Visionary" or the "Company"), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced that, effective March 4, 2024, the Company has appointed YCM CPA Inc. (the "Successor Auditors") as successor auditor of the Company and for the fiscal year ending March 31, 2024 to replace MNP LLP.
Selects YCM CPA INC. as the Company's independent registered public accounting firm was approved by the audit committee of the board of directors of the Company.
There was no disagreement between the Company and MNP LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure.

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Retrieved on:

Wednesday, January 31, 2024

TSX, MNP, Therapy, Indian stock exchange, MNP LLP, Remuneration, BCT, Shareholder

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce the results of its annual general meeting of shareholders of the Company (the “Shareholders”) for the year ended July 31, 2023 held on January 30, 2024 (the “Meeting”).

Key Points:

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce the results of its annual general meeting of shareholders of the Company (the “Shareholders”) for the year ended July 31, 2023 held on January 30, 2024 (the “Meeting”).
A total of 5,375,071 common shares of the Company (the “Common Shares”) were voted, representing 33.63% of the Company’s issued and outstanding Common Shares.
Gross, Dr. Rebecca Taub, Mr. Vaughn C. Embro-Pantalony, and Mr. Martin E. Schmieg as directors of the Company.
A total of 5,375,071 common shares were voted in connection with the election of the directors as follows:

Foremost Lithium Announces Results of AGM and Appointments

Retrieved on:

Friday, January 26, 2024

Lithium, Chartered Professional Accountant, Remuneration, MNP, MNP LLP, AGM, Management

VANCOUVER, British Columbia, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Foremost Lithium Resource & Technology Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost Lithium”, “Foremost” or the “Company”), a North American hard-rock lithium exploration company, is pleased to announce the results of the Company’s annual general and special meeting of shareholders (the “AGM”) held on January 25, 2024, in Vancouver, British Columbia.

Key Points:

VANCOUVER, British Columbia, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Foremost Lithium Resource & Technology Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost Lithium”, “Foremost” or the “Company”), a North American hard-rock lithium exploration company, is pleased to announce the results of the Company’s annual general and special meeting of shareholders (the “AGM”) held on January 25, 2024, in Vancouver, British Columbia.
The Company is pleased to report that, at its AGM, shareholders voted to elect Jason Barnard, Michael McLeod, Johnathan More, Andrew Lyons and Douglas L. Mason as directors of the Company for the ensuing year.
Furthermore, at the AGM shareholders also approved the Company’s new 2023 Stock Incentive Plan as more particularly described in the Company’s Management Information Circular which was prepared for the AGM.
Following the AGM, the Board of Directors (the “Board”) met and confirmed the appointment of the following Company executive officers:
President and Chief Executive Officer;